The transgenic construct contains a loxP-flanked lacZ-neomycin-polyA followed by a human CXCL8 (chemokine (C-X-C motif) ligand 8, also known as IL8) under the control of a CMV-enhanced chicken beta actin promoter (CAG). Founder line 1 has the highest CXCL8 (IL8) expression. (J:288179)